Mortality rates in trials of subjects with type 2 diabetes.

"Disclosures Dr. Pfeffer reports receiving grant support from Amgen, Novartis, and Sanofi-aventis, as well as consulting fees from Amgen, Anthera, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Cerenis, Eleven Biotherapeutics, GlaxoSmithKline, Hamilton Health Sciences, Karo Bio, Novartis, Roche, Salutria, Sanofi Aventis, Servier, University of Oxford. Dr Pfeffer is a coinventor on a patent that Brigham and Women's Hospital has for the use of inhibitors of the renin-angiotensin system in selected survivors of MI. His share of the licensing agreements with Novartis and Boehringer, which are irrevocably transferred to charity, are not linked to sales. Dr. Solomon reports receiving research support from Sanofi-Aventis paid through Brigham and Women's Hospital. Drs. Barkoudah, Skali, and Uno report none."

"Dr. Pfeffer reports receiving grant support from Amgen, Novartis, and Sanofi-aventis, as well as consulting fees from Amgen, Anthera, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Cerenis, Eleven Biotherapeutics, GlaxoSmithKline, Hamilton Health Sciences, Karo Bio, Novartis, Roche, Salutria, Sanofi Aventis, Servier, University of Oxford. Dr Pfeffer is a coinventor on a patent that Brigham and Women's Hospital has for the use of inhibitors of the renin-angiotensin system in selected survivors of MI. His share of the licensing agreements with Novartis and Boehringer, which are irrevocably transferred to charity, are not linked to sales. Dr. Solomon reports receiving research support from Sanofi-Aventis paid through Brigham and Women's Hospital. Drs. Barkoudah, Skali, and Uno report none."

"Clinical Trial Registration URL: http://www.ClinicalTrials.gov. Unique identifier: NCT00303979"